These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 11598854)

  • 1. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
    Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
    Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNA ploidy in endometrial cancer.
    Ikeda M; Watanabe Y; Nanjoh T; Noda K
    Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
    Terada K; Mattson D; Goo D; Shimizu D
    Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.
    Dabić MM; Nola M; Tomicić I; Dotlić S; Petrovecki M; Jukić S
    Acta Obstet Gynecol Scand; 2008; 87(3):366-72. PubMed ID: 18307079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma.
    Ferrara F; De Santis L; Mangili F; Sassi I; Luchini S; Mandelli C; Santambrogio G; Cantaboni A
    Pathol Res Pract; 1994 Nov; 190(11):1039-43. PubMed ID: 7746737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
    Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
    Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
    Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.